Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Meritor Inc (NYSE:MTOR)

Meritor Inc (NYSE:MTOR) has seen an increase in enthusiasm from smart money recently.

In the financial world, there are tons of methods market participants can use to monitor publicly traded companies. A duo of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top money managers can outclass the S&P 500 by a superb amount (see just how much).

Meritor Inc (NYSE:MTOR)Just as integral, optimistic insider trading activity is a second way to break down the marketplace. Obviously, there are plenty of incentives for an upper level exec to cut shares of his or her company, but only one, very clear reason why they would behave bullishly. Plenty of academic studies have demonstrated the market-beating potential of this method if shareholders know what to do (learn more here).

Keeping this in mind, we’re going to take a glance at the key action regarding Meritor Inc (NYSE:MTOR).

How have hedgies been trading Meritor Inc (NYSE:MTOR)?

At the end of the fourth quarter, a total of 20 of the hedge funds we track were long in this stock, a change of 11% from the previous quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their holdings meaningfully.

According to our comprehensive database, Glenview Capital, managed by Larry Robbins, holds the biggest position in Meritor Inc (NYSE:MTOR). Glenview Capital has a $45 million position in the stock, comprising 0.6% of its 13F portfolio. On Glenview Capital’s heels is Glenhill Advisors, managed by Glenn J. Krevlin, which held a $11 million position; 0.2% of its 13F portfolio is allocated to the stock. Some other hedgies that hold long positions include Chuck Royce’s Royce & Associates, Ken Griffin’s Citadel Investment Group and Jeffrey Gendell’s Tontine Asset Management.

As aggregate interest increased, key hedge funds were breaking ground themselves. Cobalt Capital Management, managed by Wayne Cooperman, established the most outsized position in Meritor Inc (NYSE:MTOR). Cobalt Capital Management had 3 million invested in the company at the end of the quarter. Glenn J. Krevlin’s Glenhill Advisors also initiated a $1 million position during the quarter. The other funds with new positions in the stock are Glenn Russell Dubin’s Highbridge Capital Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Clint Carlson’s Carlson Capital.

What have insiders been doing with Meritor Inc (NYSE:MTOR)?

Bullish insider trading is best served when the company in focus has experienced transactions within the past six months. Over the last half-year time period, Meritor Inc (NYSE:MTOR) has seen zero unique insiders purchasing, and 6 insider sales (see the details of insider trades here).

With the results demonstrated by Insider Monkey’s tactics, everyday investors should always pay attention to hedge fund and insider trading sentiment, and Meritor Inc (NYSE:MTOR) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!